Dexrazoxane (Cardioxane) as cardio - protector from anthracycline cardiotoxicity in high risk cancer patients /
استخدام عقار ديكسرازوكسان (كارديوكسان) للوقاية من اعتلال القلب الناتج عن استخدام الانثراسيكلين فى مرضى السرطان المعرضين للاصابة
Hosam Darwish Abo Gad Alla ; Supervised Mostafa Mahmoud Elserafi , Nasr Mohamed Ali Allahloby , Mohamed Sayed Ahmed
- Cairo : Hosam Darwish Abo Gad Alla , 2004
- 168P : diagrs ; 25cm
Thesis (PH.D.) - Cairo University - National Cancer Institute - Department Of Oncology
Anthracycline especially DOX are highly effective anti - neoplastic agent , so they widely used in treatment of large variety of malignant tumourThe most serious side effect of anthracycline is cardiotoxicity , the risk of cumulative toxic cardiomyopathy has an effect on the total dose of these drugs and reduce their therapeutic potential
Breast cancer Cardiac risk factors Dexrazoxane Doxorubicin cardiomyopathy